Search - tctmd.com

Displaying 1 - 20 of 35

Sort: Relevancy | Date

News Industry News

Study Finds Use Of Adjuctive Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement Was Safe But Improvement In MRI Findings Did Not Reach Statistical Significance

November 01, 2016

News Industry News

ArtVentive Medical Begins Testing the Next Generation of its EOS™ Technology

December 02, 2015

News Industry News

InspireMD Receives EU Regulatory Approval for Additional Supplier of CGuard™ Delivery Catheters

December 01, 2015

News Industry News

Praxbind® (idarucizumab) approved in European Union for the specific reversal of Pradaxa® (dabigatran etexilate)

November 29, 2015

News Industry News

First US Multi-center Study Finds Unprotected TAVR Procedures Produce New Brain Lesions in Nearly All Cases

October 14, 2015

News Industry News

InspireMD Announces Full Market Launch of CGuard™ Distributed by Penumbra at CIRSE Annual Congress

September 28, 2015

News Industry News

Acute Pulmonary Embolism Trial (SEATTLE II) Published in the JACC: Cardiovascular Interventions

August 24, 2015

News Industry News

AngioDynamics Announces First Patient Enrollment in RAPID Outcomes Database

August 06, 2015

News Industry News

InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award

July 08, 2015

News Industry News

A Significant Achievement for Allium Medical: Gardia's WIRION® Embolic Protection Device Received FDA Clearance for the Carotid Indication

June 08, 2015

News Industry News

InspireMD Announces Clinical Presentations on CGuard and MGuard Systems with MicroNet™ Technology at EuroPCR 2015 Conference

May 12, 2015

News Industry News

InspireMD Announces Important Clinical Data from MASTER and CARENET Trials

December 14, 2014

News Industry News

InspireMD Resumes MGuard Prime Sales and Prioritizes DES and Carotid - New Product Programs

October 14, 2014

News Industry News

InspireMD to Host Conference Call and Webinar and to Discuss Recently Released Results of CGuard™ CARENET Trial on September 24th

September 18, 2014

News Industry News

InspireMD Announces Positive Results from CGuard™ CARENET Trial with 0% MACE reported at 30 Days

September 16, 2014

News Industry News

Cerebral Protection Device Reduces Brain Injury Risk in Patients with Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement

September 13, 2014

News Industry News

InspireMD to Announce Results of CGuard™CARENET Trial at the TCT Innovation Session on Late Breaking Early Human Clinical Studies

August 11, 2014

News Industry News

InspireMD Announces Successful Completion of CGuardTM CARENET (CARotid Embolic protection study using microNET) Trial

July 08, 2014

News Industry News

InspireMD Receives European Regulatory Approval to Resume Manufacturing and Distribution of MGuardTM Prime EPS

June 23, 2014

News Industry News

InspireMD to Showcase Embolic Systems with MicroNetTM Technology and Results from MASTER I Trial at EuroPCR Conference

May 20, 2014

Advertisement

Study Finds Use Of Adjuctive Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement Was Safe But Improvement In MRI Findings Did Not Reach Statistical Significance

ArtVentive Medical Begins Testing the Next Generation of its EOS™ Technology

InspireMD Receives EU Regulatory Approval for Additional Supplier of CGuard™ Delivery Catheters

Praxbind® (idarucizumab) approved in European Union for the specific reversal of Pradaxa® (dabigatran etexilate)

First US Multi-center Study Finds Unprotected TAVR Procedures Produce New Brain Lesions in Nearly All Cases

InspireMD Announces Full Market Launch of CGuard™ Distributed by Penumbra at CIRSE Annual Congress

Acute Pulmonary Embolism Trial (SEATTLE II) Published in the JACC: Cardiovascular Interventions

AngioDynamics Announces First Patient Enrollment in RAPID Outcomes Database

InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award

A Significant Achievement for Allium Medical: Gardia's WIRION® Embolic Protection Device Received FDA Clearance for the Carotid Indication

InspireMD Announces Clinical Presentations on CGuard and MGuard Systems with MicroNet™ Technology at EuroPCR 2015 Conference

InspireMD Announces Important Clinical Data from MASTER and CARENET Trials

InspireMD Resumes MGuard Prime Sales and Prioritizes DES and Carotid - New Product Programs

InspireMD to Host Conference Call and Webinar and to Discuss Recently Released Results of CGuard™ CARENET Trial on September 24th

InspireMD Announces Positive Results from CGuard™ CARENET Trial with 0% MACE reported at 30 Days

Cerebral Protection Device Reduces Brain Injury Risk in Patients with Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement

InspireMD to Announce Results of CGuard™CARENET Trial at the TCT Innovation Session on Late Breaking Early Human Clinical Studies

InspireMD Announces Successful Completion of CGuardTM CARENET (CARotid Embolic protection study using microNET) Trial

InspireMD Receives European Regulatory Approval to Resume Manufacturing and Distribution of MGuardTM Prime EPS

InspireMD to Showcase Embolic Systems with MicroNetTM Technology and Results from MASTER I Trial at EuroPCR Conference

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content